Biogen Idec Biotech India Private Limited
About Biogen Idec Biotech India Private Limited
Data last updated:
Biogen Idec Biotech India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Biogen Ma Inc. Usa. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 01 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2007PTC305611. Its GSTIN is 07AADCB0723F1Z8 (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Frederick Lawson and Arijit Mukherjee.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 1/292 Ground Floor Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.77 Cr. For the same year it recorded a net profit of ₹92.05 Lakh (net margin 52.1%) and EBITDA of ₹1.41 Cr (EBITDA margin 80%). Revenue has grown at a compounded annual rate (CAGR) of 65% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Biogen Idec Biotech India has one previous CIN (Corporate Identification Number): U24232HR2007PTC036647. The current CIN is U24232DL2007PTC305611, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL2007PTC305611 | Current |
| U24232HR2007PTC036647 | Previous |
Contact details
Biogen Idec Biotech India Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 1/292 Ground Floor Janak Puri, New Delhi, Delhi, India – 110058
- IndustryLife Sciences, Biotechnology
To see the full contact details of Biogen Idec Biotech India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Biogen Idec Biotech India Private Limited
FY 2024 filings availableBiogen Idec Biotech India Private Limited reported revenue of ₹1.77 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 65% over five years. EBITDA rose 372% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹92.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 80% | ||||
| Net Profit Margin | 52.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biogen Idec Biotech India Private Limited, buy the company report.
Board of directors of Biogen Idec Biotech India Private Limited
Biogen Idec Biotech India has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Frederick Lawson Also directs: Biogen Capability Center India Private Limited | Director | 14 Sep 2017 | 9 Years 1 Months | Current |
| Arijit Mukherjee Also directs: Biogen Capability Center India Private Limited | Director | 11 Apr 2024 | 2 Years 7 Months | Current |
| Gaurav Goyal | Director | 16 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Biogen Idec Biotech India Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Phoenix Pharma Private Limited | ₹1.77 Cr (FY 2024) | 5.0% | Mumbai, Maharashtra, India | |||
| Deity Life Sciences (I) Private Limited | ₹1.77 Cr (FY 2025) | 30.0% | Sanand, Gujarat, India | |||
| Irimed Technologies Private Limited | ₹1.77 Cr (FY 2024) | 159.0% | Hyderabad, Telangana, India | |||
| Evelyn Pharmaceuticals Private Limited | ₹1.77 Cr (FY 2025) | -29.0% | Delhi, India | |||
| Alak Healthcare Private Limited | ₹1.77 Cr (FY 2024) | 393.0% | Jetpur, Gujarat, India | |||
| Biogen Idec Biotech India Private Limitedthis company | ₹1.77 Cr (FY 2024) | ₹92.05 Lakh | 52.1% | New Delhi, Delhi, India | ||
| Arafat Enterprises Private Limited | ₹1.77 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Aarcley Pharmaceutical Private Limited | ₹1.76 Cr (FY 2025) | 121.0% | Indore, Madhya Pradesh, India | |||
| Nutrite Healthcare Private Limited | ₹1.76 Cr (FY 2024) | 534486.0% | Mumbai, Maharashtra, India | |||
| Aslay Biogen Private Limited | ₹1.76 Cr (FY 2025) | 0.0% | Patna, Bihar, India | |||
| Xion Pharmaceuticals Private Limited | ₹1.76 Cr (FY 2025) | -1.0% | Pune, Maharashtra, India |
To see the full peer comparison of Biogen Idec Biotech India Private Limited, buy the company report.
Auditor
Biogen Idec Biotech India Private Limited is audited by GAURAV KAPOOR & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV KAPOOR & ASSOCIATES | FY 2019 | 021506N |
Shareholding
The shareholding of Biogen Idec Biotech India Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Biogen Idec Biotech India Private Limited, buy the company report.
Legal cases
Biogen Idec Biotech India Private Limited has 1 court case on record: 1 filed by Biogen Idec Biotech India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of Biogen Idec Biotech India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biogen Idec Biotech India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biogen Idec Biotech India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCB0723F1Z8 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biogen Idec Biotech India Private Limited, buy the company report.
Recent activity
Biogen Idec Biotech India Private Limited has 16 board changes on record since 2007: 3 appointments and 13 cessations. The latest: Arijit Mukherjee ceased to be Additional Director on 27 Sep 2024.
7 earlier events are in the company report.
Frequently asked questions
Biogen Idec Biotech India is an active private limited company based in New Delhi, Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 01 March 2007 (19+ years old) and is registered under CIN U24232DL2007PTC305611.
Biogen Idec Biotech India has 3 current directors:
- Frederick Lawson - Director
- Arijit Mukherjee - Director
- Gaurav Goyal - Director
The latest financial statements of Biogen Idec Biotech India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Biogen Idec Biotech India is 07AADCB0723F1Z8, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Biogen Idec Biotech India is U24232DL2007PTC305611. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biogen Idec Biotech India has 1 court case on record: 1 filed by the company.
Biogen Idec Biotech India was incorporated on 01 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biogen Idec Biotech India by revenue are Phoenix Pharma Private Limited, Deity Life Sciences (I) Private Limited, Irimed Technologies Private Limited, Evelyn Pharmaceuticals Private Limited, Alak Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Arijit Mukherjee ceased to be Additional Director on 27 Sep 2024. Arijit Mukherjee was appointed as Director on 11 Apr 2024. Frederick Lawson ceased to be Additional Director on 29 Sep 2017. Biogen Idec Biotech India has 16 board changes on record in total.
The registered office of Biogen Idec Biotech India is at A – 1292 Ground Floor Janak Puri, New Delhi, Delhi, India – 110058.
Biogen Idec Biotech India operates in the life sciences industry, in the biotechnology segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
